RS66401B1 - Polimorfi antifungalnog jedinjenja triazola, pc945 - Google Patents
Polimorfi antifungalnog jedinjenja triazola, pc945Info
- Publication number
- RS66401B1 RS66401B1 RS20250045A RSP20250045A RS66401B1 RS 66401 B1 RS66401 B1 RS 66401B1 RS 20250045 A RS20250045 A RS 20250045A RS P20250045 A RSP20250045 A RS P20250045A RS 66401 B1 RS66401 B1 RS 66401B1
- Authority
- RS
- Serbia
- Prior art keywords
- compound
- crystalline form
- polymorphic
- thf
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1917867.2A GB201917867D0 (en) | 2019-12-06 | 2019-12-06 | Polymorphs |
| EP20824979.7A EP4069690B1 (en) | 2019-12-06 | 2020-12-04 | Polymorphs of triazole antifungal compound pc945 |
| PCT/GB2020/053107 WO2021111142A1 (en) | 2019-12-06 | 2020-12-04 | Polymorphs of triazole antifungal compound pc945 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS66401B1 true RS66401B1 (sr) | 2025-02-28 |
Family
ID=69171938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20250045A RS66401B1 (sr) | 2019-12-06 | 2020-12-04 | Polimorfi antifungalnog jedinjenja triazola, pc945 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US12491182B2 (enExample) |
| EP (2) | EP4069690B1 (enExample) |
| JP (1) | JP2023505227A (enExample) |
| KR (1) | KR20220110726A (enExample) |
| CN (1) | CN114746415B (enExample) |
| AU (1) | AU2020397613A1 (enExample) |
| BR (1) | BR112022006259A2 (enExample) |
| CA (1) | CA3155829A1 (enExample) |
| CL (1) | CL2022001464A1 (enExample) |
| CO (1) | CO2022007808A2 (enExample) |
| DK (1) | DK4069690T3 (enExample) |
| ES (1) | ES3000984T3 (enExample) |
| FI (1) | FI4069690T3 (enExample) |
| GB (1) | GB201917867D0 (enExample) |
| HR (1) | HRP20250042T1 (enExample) |
| HU (1) | HUE069799T2 (enExample) |
| IL (1) | IL293401A (enExample) |
| LT (1) | LT4069690T (enExample) |
| MX (1) | MX2022006654A (enExample) |
| PL (1) | PL4069690T3 (enExample) |
| PT (1) | PT4069690T (enExample) |
| RS (1) | RS66401B1 (enExample) |
| SA (1) | SA522432879B1 (enExample) |
| SI (1) | SI4069690T1 (enExample) |
| SM (1) | SMT202400514T1 (enExample) |
| WO (1) | WO2021111142A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6669751B2 (ja) | 2014-12-05 | 2020-03-18 | プルモシデ リミテド | 抗真菌化合物 |
| CN117510488B (zh) * | 2022-07-28 | 2025-12-05 | 博瑞制药(苏州)有限公司 | 一种硫酸艾沙康唑的制备方法 |
| CN117330660A (zh) * | 2023-09-14 | 2024-01-02 | 广州医科大学附属第一医院（广州呼吸中心） | Uplc-ms/ms联用检测艾沙康唑的方法及应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1292472C (en) | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| EP0318214B1 (en) | 1987-11-20 | 1994-12-14 | Schering Corporation | Tri- and tetra-substituted-oxetanes and -tetrahydrofurans and intermediates thereof |
| US5039676A (en) | 1990-05-11 | 1991-08-13 | Schering Corporation | Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
| HU225062B1 (en) | 1993-12-21 | 2006-05-29 | Schering Corp | Tetrahydrofuran derivatives with antifungal- effect, pharmaceutical compositions containing them and process for their preparation |
| US5714490A (en) | 1993-12-21 | 1998-02-03 | Schering Corporation | Tetrahydrofuran antifungals |
| US5486625A (en) | 1994-07-08 | 1996-01-23 | Schering Corporation | Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents |
| CZ59497A3 (en) | 1995-06-02 | 1997-08-13 | Schering Corp | Tetrahydrofuran derivative and pharmaceutical composition containing thereof |
| EP0957101A1 (en) | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Water soluble azoles as broad-spectrum antifungals |
| EP1372394A1 (en) | 2001-04-03 | 2004-01-02 | Schering Corporation | Antifungal composition with enhanced bioavailability |
| EP2141159A1 (en) | 2008-07-03 | 2010-01-06 | Sandoz AG | A Crystalline form of posaconazole |
| US9346791B2 (en) | 2011-09-07 | 2016-05-24 | The Johns Hopkins University | Itraconazole analogs and use thereof |
| JP6669751B2 (ja) | 2014-12-05 | 2020-03-18 | プルモシデ リミテド | 抗真菌化合物 |
-
2019
- 2019-12-06 GB GBGB1917867.2A patent/GB201917867D0/en not_active Ceased
-
2020
- 2020-12-04 SI SI202030565T patent/SI4069690T1/sl unknown
- 2020-12-04 MX MX2022006654A patent/MX2022006654A/es unknown
- 2020-12-04 SM SM20240514T patent/SMT202400514T1/it unknown
- 2020-12-04 US US17/782,232 patent/US12491182B2/en active Active
- 2020-12-04 BR BR112022006259A patent/BR112022006259A2/pt unknown
- 2020-12-04 PT PT208249797T patent/PT4069690T/pt unknown
- 2020-12-04 EP EP20824979.7A patent/EP4069690B1/en active Active
- 2020-12-04 CN CN202080082529.6A patent/CN114746415B/zh active Active
- 2020-12-04 LT LTEPPCT/GB2020/053107T patent/LT4069690T/lt unknown
- 2020-12-04 JP JP2022533459A patent/JP2023505227A/ja active Pending
- 2020-12-04 KR KR1020227012753A patent/KR20220110726A/ko active Pending
- 2020-12-04 AU AU2020397613A patent/AU2020397613A1/en active Pending
- 2020-12-04 FI FIEP20824979.7T patent/FI4069690T3/fi active
- 2020-12-04 CA CA3155829A patent/CA3155829A1/en active Pending
- 2020-12-04 ES ES20824979T patent/ES3000984T3/es active Active
- 2020-12-04 IL IL293401A patent/IL293401A/en unknown
- 2020-12-04 PL PL20824979.7T patent/PL4069690T3/pl unknown
- 2020-12-04 DK DK20824979.7T patent/DK4069690T3/da active
- 2020-12-04 RS RS20250045A patent/RS66401B1/sr unknown
- 2020-12-04 WO PCT/GB2020/053107 patent/WO2021111142A1/en not_active Ceased
- 2020-12-04 EP EP24212504.5A patent/EP4509179A3/en active Pending
- 2020-12-04 HU HUE20824979A patent/HUE069799T2/hu unknown
- 2020-12-04 HR HRP20250042TT patent/HRP20250042T1/hr unknown
-
2022
- 2022-06-01 CO CONC2022/0007808A patent/CO2022007808A2/es unknown
- 2022-06-02 CL CL2022001464A patent/CL2022001464A1/es unknown
- 2022-06-05 SA SA522432879A patent/SA522432879B1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4069690B1 (en) | 2024-11-13 |
| PL4069690T3 (pl) | 2025-03-10 |
| DK4069690T3 (da) | 2025-01-20 |
| ES3000984T3 (es) | 2025-03-04 |
| FI4069690T3 (fi) | 2025-01-21 |
| US20230028714A1 (en) | 2023-01-26 |
| EP4069690A1 (en) | 2022-10-12 |
| CO2022007808A2 (es) | 2022-06-30 |
| MX2022006654A (es) | 2022-09-07 |
| CN114746415A (zh) | 2022-07-12 |
| JP2023505227A (ja) | 2023-02-08 |
| SA522432879B1 (ar) | 2025-01-26 |
| CA3155829A1 (en) | 2021-06-10 |
| CN114746415B (zh) | 2025-04-11 |
| US12491182B2 (en) | 2025-12-09 |
| PT4069690T (pt) | 2024-12-13 |
| CL2022001464A1 (es) | 2023-03-24 |
| SI4069690T1 (sl) | 2025-03-31 |
| LT4069690T (lt) | 2025-01-10 |
| IL293401A (en) | 2022-07-01 |
| BR112022006259A2 (pt) | 2022-06-21 |
| EP4509179A2 (en) | 2025-02-19 |
| GB201917867D0 (en) | 2020-01-22 |
| HRP20250042T1 (hr) | 2025-03-14 |
| HUE069799T2 (hu) | 2025-04-28 |
| AU2020397613A1 (en) | 2022-06-02 |
| KR20220110726A (ko) | 2022-08-09 |
| WO2021111142A1 (en) | 2021-06-10 |
| SMT202400514T1 (it) | 2025-01-14 |
| EP4509179A3 (en) | 2025-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101980698B (zh) | 盐酸苯达莫司汀固体形式 | |
| US9642799B2 (en) | Crystalline 6-(2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-0X0-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5-ynamide | |
| RS66401B1 (sr) | Polimorfi antifungalnog jedinjenja triazola, pc945 | |
| US20090175802A1 (en) | Tiotropium containing hfc solution formulations | |
| BR112017008481B1 (pt) | Composto antimicótico, uso do referido composto, composição farmacêutica e processo para preparar o mesmo | |
| EP3490978B1 (en) | Salts of 2, 6-dimethylpyrimidone derivatives and uses thereof | |
| US10513511B2 (en) | Aqueous suspension formulation comprising 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluoro-phenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl) or a pharmaceutically acceptable salt thereof | |
| HK40124005A (en) | Polymorphs | |
| EA048470B1 (ru) | Полиморфы триазольного противогрибкового соединения pc945 | |
| HK40082086A (en) | Polymorphs of triazole antifungal compound pc945 | |
| HK40082086B (en) | Polymorphs of triazole antifungal compound pc945 | |
| US12281077B2 (en) | Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]pyridine-2-carboxamide | |
| WO2021014169A1 (en) | Crystalline form of 4-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]-n-cyclohexyl-pyridine-2-carboxamide | |
| HK40009059A (en) | Salts of 2, 6-dimethylpyrimidone derivatives and uses thereof | |
| EP2743255A1 (en) | Cocrystal of agomelatine with phosphoric acid | |
| BR112017020807B1 (pt) | Composto 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-il)metil)-5-(2,4- difluorofenil)tetra-hidrofuran-3-il)metóxi)-3-metilfenil)piperazin-1-il)-n-(2- hidroxiciclo-hexil) benzamida antifúngica, seu processo de preparação, e composição farmacêutica | |
| HK1252779B (en) | Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1-yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof |